A Placebo-Controlled Double-Blind Combined Treatment of Modafinil and CBT for Cocaine Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

March 31, 2007

Conditions
Cocaine Dependence
Interventions
DRUG

Modafinil

During the first lead-in week, participants will attend the clinic 3 times per week, participate in one session of neuropsychological assessment and receive motivational interviewing and Cognitive Behavioral Therapy--Relapse Prevention (CBT-RP). At the end of the first lead-in week participants will be randomized to modafinil or placebo stratified by the levels of cocaine use, and whether or not abstinence was achieved. Participants will then be followed for 11 weeks with measures of cocaine cravings and withdrawal, and drug use outcome, and will receive CBT-RP.

BEHAVIORAL

Cognitive Behavioral Therapy--Relapse Prevention

Once weekly individual session of motivational interviewing and Cognitive Behavioral Therapy--Relapse Prevention (CBT-RP)

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Research Foundation for Mental Hygiene, Inc.

OTHER

NCT00344565 - A Placebo-Controlled Double-Blind Combined Treatment of Modafinil and CBT for Cocaine Dependence | Biotech Hunter | Biotech Hunter